Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Journal.
Press releases published on May 15, 2025
Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting
GlobeNewswire
·
May 15, 2025
Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled for Thursday, May 15, 2025, at 11:36 a.m. PT PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) …
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
GlobeNewswire
·
May 15, 2025
WARSAW, Poland, May 15, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …
HODL 2025 opens in Dubai, advancing the Emirates' position as a global financial innovation hub
GlobeNewswire
·
May 15, 2025
DUBAI, United Arab Emirates, May 15, 2025 (GLOBE NEWSWIRE) -- HODL 2025, organised by Trescon, the world's longest-running Web3 event, officially opened today at Madinat Jumeirah, Dubai, marking a pivotal moment in the evolution of blockchain and …
Laser Hair Removal Market Size to Surpass USD 1.46 Billion by 2031 with CAGR of 13.31% | The Insight Partners
GlobeNewswire
·
May 15, 2025
US …
SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025
GlobeNewswire
·
May 15, 2025
Positive interim 2-week safety and biomarker results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (“IPF”) Continued momentum with completed patient enrollment for the 6-week interim analysis (n=24) …
VCI Global’s Fintech Arm Advances Toward Full Digital Lending Rollout with Regulatory Approval, Targeting Two-Minute Loan Disbursements
GlobeNewswire
·
May 15, 2025
KUALA LUMPUR, Malaysia, May 15, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”) today announced that its fintech subsidiary, Credilab Sdn Bhd (“Credilab” or the “Company”) has secured a conditional approval for a digital …
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
GlobeNewswire
·
May 15, 2025
BERKELEY HEIGHTS, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the RBC …
XRP News: 24 Hours to Go! Vaultro Finance Set to Reveal the First Decentralized Index Fund Dashboard on XRPL
GlobeNewswire
·
May 15, 2025
SINGAPORE, May 15, 2025 (GLOBE NEWSWIRE) -- The countdown is nearly over. In less than 24 hours, Vaultro Finance will officially unveil the first-ever decentralized index fund dashboard built entirely on the XRP Ledger — a breakthrough that’s already …
Velani Jewelry: Top-Ranked Guam Jewelry Store Surpasses 5,000 Customers Served
EIN Presswire
·
May 15, 2025
Guam-based Velani Jewelry serves 5,000+ customers with waterproof, hypoallergenic designs sold at weekly pop-ups across the island. HAGåTñA, GUAM, May 15, 2025 /EINPresswire.com/ -- Velani Jewelry, a Guam jewelry store, has earned a Top 3 ranking in …
엣지 AI 및 비전 협회, 한국 중소기업과 스타트업의 북미 비즈니스 기회 창출 지원
EIN Presswire
·
May 15, 2025
INCHEON, SOUTH KOREA, May 15, 2025 /EINPresswire.com/ -- 엔지니어들이 주변 세계를 인식하고 이해하는 제품을 설계하도록 영감을 주고 역량을 강화하는 데 전념하는 최고의 단체인 엣지 AI 및 비전 협회 (이하 엣지 AI 협회)는 혁신적인 한국 스타트업을 위해 북미에서 중요한 비즈니스 기회와 파트너십을 적극적으로 촉진하고 있습니다. 광범위한 네트워크와 영향력 있는 연례 컨퍼런스인 비전 서밋(Vision …
Reflect Scientific Advances Market Presence by Transitioning from OTCQB to OTCIQ
GlobeNewswire
·
May 15, 2025
OREM, Utah, May 15, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of innovative cryogenic technologies for the life sciences and biotech industries, today announced that it is actively transitioning from the OTCQB Venture …
Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
·
May 15, 2025
In vitro testing with CDI-988 demonstrated superior broad-spectrum antiviral activity against major norovirus variants BOTHELL, Wash., May 15, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial …
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
GlobeNewswire
·
May 15, 2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has received approval from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic …
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
GlobeNewswire
·
May 15, 2025
Brekiya® becomes the first and only DHE autoinjector that allows patients to self-administer the same medication used in hospitals in a ready-to-use form Product will be available for appropriate patients in the second half of 2025 BRIDGEWATER, N.J., May …
Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
GlobeNewswire
·
May 15, 2025
Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L NSCLC) Notably, ~92% of all evaluable patients have PD-L1 TPS <50%, including 43% with PD-L1 below 1 (TPS <1%), who represent an area …
Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 15, 2025
NEW YORK and MELBOURNE, Australia, May 15, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing oral combination medicines, today reported fiscal second …
ZJK Industrial Co. Ltd. Secures Patent from the China National Intellectual Property Administration for High-Precision Image Recognition-based SMT Carrier Tape Inspection System, Boosting Automation and Efficiency
GlobeNewswire
·
May 15, 2025
Shenzhen, China, May 15, 2025 (GLOBE NEWSWIRE) -- ZJK Industrial Co. Ltd. (NASDAQ: ZJK) (“ZJK Industrial”, “ZJK” or the “Company”), a high-tech precision parts and hardware manufacturer for artificial intelligence (AI) infrastructure, consumer electronics, …
Polpharma Group fordert dringende Maßnahmen zum Schutz eines frühzeitigen und gerechten Zugangs zu Medikamenten für europäische Patienten
GlobeNewswire
·
May 15, 2025
WARSCHAU, Polen, May 15, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, ein führendes Pharmaunternehmen, fordert die Europäische Union nachdrücklich auf, entschlossene Maßnahmen zu ergreifen, um die Arzneimittelreform abzuschließen und die Kapazitäten …
Polpharma Group plaide en faveur d’une action urgente en vue de garantir aux patients européens un accès équitable et précoce aux médicaments
GlobeNewswire
·
May 15, 2025
VARSOVIE, Pologne, 15 mai 2025 (GLOBE NEWSWIRE) -- Polpharma Group, acteur pharmaceutique de première importance, enjoint l’Union européenne à arrêter des mesures décisives pour finaliser la réforme du secteur pharmaceutique et renforcer la capacité du …